- Home
- Publications
- Publication Search
- Publication Details
Title
HER2-Positive Endometrial Cancer Subtype Carries Poor Prognosis
Authors
Keywords
-
Journal
CTS-Clinical and Translational Science
Volume 7, Issue 6, Pages 482-488
Publisher
Wiley
Online
2014-09-09
DOI
10.1111/cts.12207
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HER2/neuin Endometrial Cancer: A Promising Therapeutic Target With Diagnostic Challenges
- (2014) Natalia Buza et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial
- (2013) Jone Trovik et al. EUROPEAN JOURNAL OF CANCER
- Expression of Estrogen Receptor-α as a Prognostic Factor in Patients With Uterine Serous Carcinoma
- (2013) Tomoko Sho et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX
- (2013) Otto Metzger-Filho et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade
- (2013) Rie Urabe et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma
- (2013) Jui Lan et al. TUMOR BIOLOGY
- The Value of Immunohistochemical Determination of Topoisomerase IIα and Ki67 as Markers of Cell Proliferation and Malignant Transformation in Colonic Mucosa
- (2013) Ivana Knezevic Stromar et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Expression of Topoisomerase II-α in Triple Negative Breast Cancer
- (2013) Ivana Mrklić et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
- (2012) D H Morrison et al. BRITISH JOURNAL OF CANCER
- Clinicopathological and prognostic impact of human epidermal growth factor receptor type 2 (HER2) and hormone receptor expression in uterine papillary serous carcinoma
- (2012) Shinichi Togami et al. CANCER SCIENCE
- Molecular pathology of endometrial carcinoma
- (2012) Xavier Matias-Guiu et al. HISTOPATHOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Tumor-associated macrophages, epidermal growth factor receptor correlated with the triple negative phenotype in endometrial endometrioid adenocarcinoma
- (2012) Xue-feng Jiang et al. PATHOLOGY RESEARCH AND PRACTICE
- Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
- (2012) Jan Budczies et al. PLoS One
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
- (2011) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- CD73 Expression as a Potential Marker of Good Prognosis in Breast Carcinoma
- (2011) Anna Supernat et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- The prognostic significance of the triple negative phenotype in endometrial cancer
- (2010) Rajul Kothari et al. GYNECOLOGIC ONCOLOGY
- Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium
- (2009) Sergio Pecorelli INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started